Updated January 30, 2019 The eighth Risperdal case is set to go to trial, this time the stakes are even higher for both sides as the jury may award punitive damages to the

In Stephen Sheller’s book Lawyering In Times of Saints and Evil Doers (2015), Sheller tells the story of science for sale, the widespread conflict of interest created when doctors and researchers are influenced by payments

The Pennsylvania Superior Court has upheld the 2015 $2.5 million Risperdal verdict for plaintiff Austin Pledger. Pledger’s case was the first Risperdal case to go to trial. Viewed as a huge win for

After years of litigation and several court losses for harm caused by Risperdal, Johnson & Johnson’s legal team agreed to settle the suit of a young boy from Mississippi who claims he developed female-like

“I did a little math. About 150 Americans are going to die today, just today, while we’re meeting.” -Judge Dan Polster October 5, 2018, U.S. Magistrate Judge David Ruiz of the Northern District

In support The Sheller Center for Social Justice’s mission, Stephen and Sandra Sheller have donated an additional $1.5 million to the Temple University Beasley School of Law. The Center takes on social justice issues for underserved

Philadelphia Court of Common Pleas Judge Arnold L. New has ordered two Risperdal cases to proceed in a new trial for punitive damages. In both cases, causation and compensatory damage were already awarded the

Stephen and Sandra Sheller were honored July 13, 2018 at the Salvation Army’s “Celebration of Philanthropy” event announcing the new Stephen and Sandy Sheller Emergency Disaster Service Command Center. The command center was

The PA Supreme Court has agreed to review a Superior Court decision which would dismiss thousands of Risperdal cases due to statute of limitations. The two cases on appeal, Saksek v. Janssen and Winter v. Janssen,

Juries across the country have been handing down “eye catching” verdicts for plaintiffs with ovarian cancer and their families against Johnson & Johnson. The most recent included a nearly $4.7 billion verdict for